NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/30/2023
Back to search
Official data from USPTO
CYCART19
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
05/30/2023
Trademark type
Word
Nice classes
1, 5
Filing date
06/10/2021
Registration date
05/30/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/30/2023
Last transaction
05/30/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/07/2020
First use in commerce
06/02/2021
Drawing code
4
Owner type
03
Owner location
Florham Park, NJ
Examiner
CHOI, REBECCA
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Celularity Inc.
Representatives
Camille M. Miller COZEN O'CONNOR
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
bioengineered cells for use in scientificlaboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientificlaboratory and medical research; placental-derived cellschimeric antigen receptor (CAR) T cellsplacental-derived T cells with a chimeric antigen receptor (CAR)all for use in scientificlaboratory and medical research
Class 5
Cells and biological preparations intended for medical and clinical usebloodstem cellsplacental-derived cellsumbilical cord cellsplacental-derived T cellschimeric antigen receptor (CAR) T cellsumbilical cord bloodplacental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical useplacental-derived natural killer cellsplacental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; biological tissue intended for use as a wound covering and burn dressing; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds and burns; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical useplacental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen
Publications
History of USPTO decisions and trademark events.
31 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/30/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/14/2023
PUBO
PUBLISHED FOR OPPOSITION
03/14/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/06/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
02/03/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/03/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
02/03/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/03/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/16/2022
EXPI
EX PARTE APPEAL-INSTITUTED
12/16/2022
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
12/16/2022
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
12/16/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/16/2022
GNFR
FINAL REFUSAL E-MAILED
06/16/2022
CNFR
FINAL REFUSAL WRITTEN
06/16/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/13/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/12/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/12/2022
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
03/09/2022
IUAA
USE AMENDMENT ACCEPTED
03/08/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/08/2022
GNRT
NON-FINAL ACTION E-MAILED
03/08/2022
CNRT
NON-FINAL ACTION WRITTEN
03/08/2022
DOCK
ASSIGNED TO EXAMINER
03/01/2022
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
09/02/2021
IUAF
USE AMENDMENT FILED
09/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/31/2021
EAAU
TEAS AMENDMENT OF USE RECEIVED
06/15/2021
NWAP
NEW APPLICATION ENTERED
06/14/2021
Continuous trademark protection
Get notified about every new filing that threatens CYCART19 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.